The LymeX Authorization Act aims to enhance efforts in combating Lyme disease by promoting innovation in its prevention, diagnosis, and treatment. The main goal is to stimulate advancements in healthcare related to this disease through the use of prize competitions, which can encourage creative solutions from various sectors. Key provisions of the Act include the establishment of a funding mechanism that authorizes the Secretary of Health and Human Services to allocate $5 million for prize competitions.